First Citizens Bank & Trust’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,505
Closed -$443K 629
2025
Q2
$443K Buy
+4,505
New +$426K 0.01% 454
2022
Q2
Sell
-1,420
Closed -$245K 398
2022
Q1
$245K Buy
1,420
+50
+4% +$7.47K 0.01% 360
2021
Q4
$222K Buy
+1,370
New +$220K 0.01% 390
2021
Q3
Sell
-884
Closed -$217K 413
2021
Q2
$217K Sell
884
-114
-11% -$29.9K 0.01% 387
2021
Q1
$264K Sell
998
-41
-4% -$11.6K 0.01% 330
2020
Q4
$305K Sell
1,039
-16
-2% -$4.1K 0.02% 266
2020
Q3
$249K Hold
1,055
0.02% 290
2020
Q2
$209K Sell
1,055
-340
-24% -$63.4K 0.02% 350
2020
Q1
$256K Buy
1,395
+101
+8% +$18K 0.03% 243
2019
Q4
$216K Buy
+1,294
New +$192K 0.02% 327
2019
Q3
Sell
-3,228
Closed -$392K 368
2019
Q2
$392K Buy
+3,228
New +$383K 0.04% 315

Other funds holding AMED

First Citizens Bank & Trust's AMED Position: Q3 2025 in Review

First Citizens Bank & Trust sold out of Amedisys (AMED) in Q3 2025, closing a stake of 4,505 shares — an estimated $443K sold.

First Citizens Bank & Trust first reported a position in AMED in Q2 2019 and held it in 11 quarters. The position peaked at $443K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • First Citizens Bank & Trust reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • First Citizens Bank & Trust sold 4,505 Amedisys shares in Q3 2025, an estimated $443K.
  • First Citizens Bank & Trust first reported a position in Amedisys in Q2 2019 and held it in 11 quarters.
  • First Citizens Bank & Trust's Amedisys position peaked at $443K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on First Citizens Bank & Trust's 13F filing for Q3 2025, filed 31 Oct 2025.